Press Releases

Press Releases

Filters
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
Viatris Statement Regarding European Commission’s Approval for Proposed Divestiture of its Over-the-Counter Business to Cooper Consumer Health
Viatris Named to TIME's World's Most Sustainable Companies 2024 List
Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024
Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Viatris Statement on the Close of the Active Pharmaceutical Ingredients Business Divestiture
Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors
Viatris to Participate in the Jeffries Global Healthcare Conference
Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale
Displaying 1 - 10 of 108